Clinical trial
BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid…
NCT00458861 · Biogen, Industry · Terminated
Key facts
| NCT number | NCT00458861 |
|---|---|
| Title | BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis |
| Official title | A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, PK, and PD of BG9924 When Given in Combo With MTX to Subjects With Active RA Who Have Had an Inadequate Response to Anti-TNF |
| Lead sponsor | Biogen, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological, Other |
| Interventions | BG9924, Placebo Comparator |
| Enrollment | 115 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Apr 11, 2007 |
| Last update posted | Jan 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: